We observed a significantly higher increase in the frequency of CD4+ IL-17A+/IL-10+ secreting cells in AML patients than in HV, whereas the percentage of IL-17A+/IFN-γ+ cells remained unchanged. The gene discussed is IL10; the disease is acute myeloid leukemia.